Cytomegalovirus in Solid Organ Transplant Recipients

被引：238

作者：

Humar, A. ^{[1
]}

Snydman, D. ^{[2
]}

机构：

[1] Univ Alberta, Dept Med, Transplant Infect Dis, Edmonton, AB, Canada

[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷

关键词：

Cytomegalovirus; ganciclovir; preemptive therapy; prophylaxis; GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS; IMMUNE GLOBULIN PROPHYLAXIS; AMPLICOR CMV MONITOR; CLINICAL UTILITY; VIRAL-LOAD; ORAL GANCICLOVIR; VALGANCICLOVIR PROPHYLAXIS; INTRAVENOUS GANCICLOVIR; LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION;

D O I：

10.1111/j.1600-6143.2009.02897.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：S78 / S86

页数：9

共 45 条

[1] Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients [J].

Asberg, A. ;

Humar, A. ;

Rollag, H. ;

Jardine, A. G. ;

Mouas, H. ;

Pescovitz, M. D. ;

Sgarabotto, D. ;

Tuncer, M. ;

Noronha, I. L. ;

Hartmann, A. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (09) :2106-2113

[2] Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients [J].

Asberg, A. ;

Humar, A. ;

Jardine, A. G. ;

Rollag, H. ;

Pescovitz, M. D. ;

Mouas, H. ;

Bignamini, A. ;

Toez, H. ;

Dittmer, I. ;

Montejo, M. ;

Hartmann, A. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) :1205-1213

[3] Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients [J].

Bhorade, SM ;

Lurain, NS ;

Jordan, A ;

Leischner, J ;

Villanueva, J ;

Durazo, R ;

Creech, S ;

Vigneswaran, WT ;

Garrity, ER .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (12) :1274-1282

[4] Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients [J].

Boivin, G ;

Goyette, N ;

Gilbert, C ;

Roberts, N ;

Macey, K ;

Paya, C ;

Pescovitz, MD ;

Humar, A ;

Dominguez, E ;

Washburn, K ;

Blumberg, E ;

Alexander, B ;

Freeman, R ;

Heaton, N ;

Covington, E .

JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (09) :1615-1618

[5]

Caliendo AM, 2000, J CLIN MICROBIOL, V38, P2122

[6]

CONTI DJ, 1995, ARCH SURG-CHICAGO, V130, P1217

[7] Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation [J].

Emery, VC ;

Sabin, CA ;

Cope, AV ;

Gor, D ;

Hassan-Walker, AF ;

Griffiths, PD .

LANCET, 2000, 355 (9220) :2032-2036

[8] Cytomegalovirus in transplantation -: challenging the status quo [J].

Fishman, Jay A. ;

Emery, Vincent ;

Freeman, Richard ;

Pascual, Manuel ;

Rostaing, Lionel ;

Schlitt, Hans J. ;

Sgarabotto, Dino ;

Torre-Cisneros, Julian ;

Uknis, Marc E. .

CLINICAL TRANSPLANTATION, 2007, 21 (02) :149-158

[9] Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [J].

Gane, E ;

Saliba, F ;

Valdecasas, GJC ;

OGrady, J ;

Pescovitz, MD ;

Lyman, S ;

Robinson, CA .

LANCET, 1997, 350 (9093) :1729-1733

[10] CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients [J].

Green, M. ;

Michaels, M. G. ;

Katz, B. Z. ;

Burroughs, M. ;

Gerber, D. ;

Shneider, B. L. ;

Newell, K. ;

Rowe, D. ;

Reyes, J. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (08) :1906-1912

← 1 2 3 4 5 →